Anbio Biotechnology (NASDAQ:NNNN) Shares Down 18.5% – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNN)’s share price fell 18.5% during mid-day trading on Monday . The company traded as low as $18.28 and last traded at $18.7480. 12,022 shares traded hands during trading, a decline of 72% from the average session volume of 43,236 shares. The stock had previously closed at $22.99.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, May 14th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of “Hold”.

Anbio Biotechnology Stock Performance

The company’s fifty day simple moving average is $27.93.

Anbio Biotechnology (NASDAQ:NNNN) last released its quarterly earnings data on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.